kt 6149 has been researched along with Lung Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D | 1 |
Bando, T; Fujimura, M; Heki, U; Iwasa, K; Kasahara, K; Matsuda, T; Numata, Y; Shibata, K; Shirasaki, H | 1 |
Fukuoka, K; Ishida, T; Kurokawa, H; Nishio, K; Saijo, N | 1 |
Saijo, N | 1 |
Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T | 1 |
2 review(s) available for kt 6149 and Lung Neoplasms
Article | Year |
---|---|
[gamma-Glutamylcysteine synthetase and chemosensitivity].
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutamate-Cysteine Ligase; Humans; Lung Neoplasms; Mice; Mitomycin; Mitomycins; RNA, Messenger | 1997 |
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 1998 |
1 trial(s) available for kt 6149 and Lung Neoplasms
Article | Year |
---|---|
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Unknown Primary; Salvage Therapy | 1995 |
2 other study(ies) available for kt 6149 and Lung Neoplasms
Article | Year |
---|---|
Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
Topics: Antineoplastic Agents; Antioxidants; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Hypoxia; Cyclic N-Oxides; Cytochrome Reductases; Cytochrome-B(5) Reductase; Drug Combinations; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); Spin Labels; Tumor Cells, Cultured | 1996 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation | 1990 |